Consumer | Research Reports, News, Events, Research on Demand

Research Reports Titles

  • Glomerulonephritis - Market Insights, Epidemiology and Market Forecast-2023

    Note*: This report requires 7-10 business days to complete. DelveInsight s Glomerulonephritis - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Glomerulonephritis for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Glomerulonephritis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Glomerulonephritis till 2023. Key Coverage and Benefits " The report will help in developing business strategies by understanding the trends shaping and driving the global Glomerulonephritis market. " Identifying patient populations in the global  Glomerulonephritis market to improve product design, pricing, and launch plans. " Organize sales and marketing efforts by identifying the best opportunities for Glomerulonephritis therapeutics in each of the markets covered. " To understand the future market competition in the global Glomerulonephritis therapeutics market and Insightful review of the key market drivers and barriers. Scope " Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options. " Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018. " The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023. " It also provides Glomerulonephritis for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

    • Release Date: August 01, 2016
    • Price: USD 4950
    • Format: pdf

  • Global and China Traumatic Orthopedic Products Research Report to 2020

    This report studies Traumatic Orthopedic Products in Global and China market, focuses on top manufacturers in global and China market, involving Traumatic Orthopedic Products price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Traumatic Orthopedic Products in USA, EU, China, Japan, and , forecast to 2020, from 2011. Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering Bone Plate Bone Screw Intramedullary nail Cannulated Screw Split by manufacturers, this report focuses on the production, price of each type, average price of Traumatic Orthopedic Products, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering Medtronic Johnson&Johnson Zimmer & Biomet Stryker Smith & Nephew Cardinal Health Weigao Orthopedics Trauson NATON Medical Double Medical Dean Orthopedics Changzhou Orthmed Changzhou Kanghui Tianjin Walkman Sanyou Medical Split by applications, this report focuses on consumption and growth rate of Traumatic Orthopedic Products in each application, can be divided into External Fixation Internal Fixation Split by regions, this report focuses on the production, revenue, consumption and market share of Traumatic Orthopedic Products in these regions, from 2011 to 2020 (forecast), covering USA EU Japan China

    • Release Date: June 29, 2016
    • Price: USD 2750
    • Format: PDF

  • Global and China Anti Peptic Ulcer Drugs Research Report to 202

    This report studies Anti Peptic Ulcer Drugs in Global and China market, focuses on top manufacturers in global and China market, involving Anti Peptic Ulcer Drugs price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Anti Peptic Ulcer Drugs in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011. Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering Proton pump inhibitor (PPI) H2 receptor antagonist Antacid Gastric mucosal protective drugs Antibiotics Other types Split by manufacturers, this report focuses on the production, price of each type, average price of Anti Peptic Ulcer Drugs, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering AstraZeneca Daewoong Pharmaceutical Eisai Co Takeda Pharmaceuticals Abbott Laboratories Cadila Healthcare Ltd. Boehringer Ingelheim GmbH Yuhan Corporation GlaxoSmithKline Changzhou Siyao Pharmaceticals AOSAIKANG HUADONG MEDICINE Yantze Pharmaceutical Group Jiangsu Wuzhong Pharmaceutical Group Xian Janssen Split by applications, this report focuses on consumption and growth rate of Anti Peptic Ulcer Drugs in each application, can be divided into Gastritis Gastric Ulcer Duodenal Ulcer Gastroesophageal Reflux Disease (GERD) Split by regions, this report focuses on the production, revenue, consumption and market share of Anti Peptic Ulcer Drugs in these regions, from 2011 to 2020 (forecast), covering USA EU Japan China India Southeast Asia

    • Release Date: June 29, 2016
    • Price: USD 2950
    • Format: PDF

  • Global and China Orphan Drugs Research Report to 202

    This report studies Orphan Drugs in Global and China market, focuses on top manufacturers in global and China market, involving Orphan Drugs price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Orphan Drugs in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011. Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering Orphan drugs for Oncology Orphan drugs for Hematology Orphan drugs for Musculoskeletal Orphan drugs for Neurology Orphan drugs for Endocrine Orphan drugs for Metabolic Orphan drugs for Others disease Split by manufacturers, this report focuses on the production, price of each type, average price of Orphan Drugs, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering Bayer Bristol-Myers Squibb Novartis Pfizer Roche Sanofi Johnson & Johnson Eli Lilly & Co. Celgene Biogen IDEC Pharmacyclics Vertex Onyx AstraZeneca Baxter Split by regions, this report focuses on the production, revenue, consumption and market share of Orphan Drugs in these regions, from 2011 to 2020 (forecast), covering USA EU Japan China India Southeast Asia

    • Release Date: June 29, 2016
    • Price: USD 2950
    • Format: PDF

  • Global and China Polylactide Acid Research Report to 2020

    This report studies Polylactide Acid in Global and China market, focuses on top manufacturers in global and China market, involving Polylactide Acid price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Polylactide Acid in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011. The growth rate of global market of Polylactide Acid is estimated at 20%-30% and the whole market is between 300 thousand tons to 500 thousand tons. North America is the biggest market in the world and holds nearly 40% of the world, followed by Europe and Asia Pacific markets. Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering Blister grade Injection Molding grade Fiber grade High-gloss pure Split by manufacturers, this report focuses on the production, price of each type, average price of Polylactide Acid, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering NatureWorks (US) Synbra (Holland) Sulzer (Switzerland) Futerro (Germany) TEIJIN (Japan) Pyramis&German Bioplastics (Germany) Zhejiang Hisun Biomaterials Co. Ltd. (China) Esun Industrial Co., Ltd. (China) Corbion Purac (Holland) Split by applications, this report focuses on consumption and growth rate of Polylactide Acid in each application, can be divided into Automobile Disposable supplies Electronics Medical Split by regions, this report focuses on the production, revenue, consumption and market share of Polylactide Acid in these regions, from 2011 to 2020 (forecast), covering China USA EU Japan Southeast Asia India

    • Release Date: June 29, 2016
    • Price: USD 2950
    • Format: PDF

  • Global and China Prescription Dermatological Drugs Research Report to 202

    This report studies Prescription Dermatological Drugs in Global and China market, focuses on top manufacturers in global and China market, involving Prescription Dermatological Drugs price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Prescription Dermatological Drugs in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011. Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering Prescription Acne and Rosacea Drugs Prescription Antiaging and Photodamage Drugs Prescription Dermatitis and Seborrhea Drugs Prescription Fungal Infection Drugs Prescription Hair Loss and Hair Removal Drugs Other Prescription Skin Disorder Drug Split by manufacturers, this report focuses on the production, price of each type, average price of Prescription Dermatological Drugs, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering Allergan Bayer AG Galderma S.A. Genentech, Inc. Johnson & Johnson AbbVie, Inc. Bristol-Myers Squibb GlaxoSmithKline Plc Merck & Company, Inc. Mylan N.V Novartis Pfizer, Inc. Sinclair IS Pharma Plc. Valeant Pharmaceuticals International Split by regions, this report focuses on the production, revenue, consumption and market share of Prescription Dermatological Drugs in these regions, from 2011 to 2020 (forecast), covering USA EU Japan China India Southeast Asia

    • Release Date: June 29, 2016
    • Price: USD 2950
    • Format: PDF

  • Global Organic Acids Market Research Report to 2020

    This report studies Organic Acids in Global market, especially in North America, Europe, Asia Pacific and ROW focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering BASF SE The DOW Chemical Company Cargill, Inc E. I. Du Pont De Nemours and Company Tate & Lyle PLC Eastman Chemical Company Myriant Corporation Calanese Corporation Henan Jindan Lactic Acid Technology Co. Ltd Archer Daniels Midland Company Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Organic Acids in these regions, from 2011-2021 (forecast), like North America Europe Asia Pacific ROW Split by product types, with production, revenue, price, market share and growth rate of each type, can be divided into Acetic Acid Citric Acid Formic Acid Lactic Acid Propionic Acid Ascorbic Acid Gluconic Acid Fumaric Acid Other Acids Split by applications, this report focuses on consumption, market share and growth rate of Organic Acids in each application, can be divided into Food Feed Industrial

    • Release Date: June 29, 2016
    • Price: USD 2850
    • Format: PDF

  • Global Syngas & Derivatives Market Research Report to 2020

    This report studies Syngas & Derivatives in Global market, especially in North America, Europe, Middle East & Africa , Asia Pacific ?South America and ROW, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering KBR Inc. Haldor Topsoe A/S Air Liquide SA Air Products and Chemicals, Inc The Linde Group Agrium Inc. Sasol Limited Royal Dutch Shell PLC Technip S.A. General Electric Company Yara International ASA Methanex Corporation CF Industries Holdings Inc. Linc Energy Ltd. Siemens Ag Chicago Bridge & Iron Company N.V. The DOW Chemical Company BASF SE Mitsubishi Heavy Industries, Ltd. (MHI Group) Oxea Gmbh (Oman Oil Company) Biomethanol Chemie Nederland B.V. KT-Kinetics Technology Syngas Technology LLC AMEC Foster Wheeler PLC Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Syngas & Derivatives in these regions, from 2011-2021 (forecast), like North America Europe Asia Pacific Middle East & Africa South America ROW Split by product types, with production, revenue, price, market share and growth rate of each type, can be divided into Fixed (Moving) Bed Entrained Flow Fluidized Bed Others Type Split by applications, this report focuses on consumption, market share and growth rate of Syngas & Derivatives in each application, can be divided into Chemical Liquid Fuels Power Generation Gaseous Fuels

    • Release Date: June 29, 2016
    • Price: USD 2850
    • Format: PDF

  • Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct s,  Prostate Cancer - Pipeline Review, H1 2016 , provides an overview of the Prostate Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Prostate Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Prostate Cancer and features dormant and discontinued projects. Global Markets Direct s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the global therapeutic landscape of Prostate Cancer - The report reviews pipeline therapeutics for Prostate Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Prostate Cancer therapeutics and enlists all their major and minor projects - The report assesses Prostate Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Prostate Cancer Reasons to buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Prostate Cancer - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Prostate Cancer pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

    • Release Date: June 28, 2016
    • Price: USD 2500
    • Format: pdf

  • Pancreatic Cancer - Pipeline Review, H1 2016

    Pancreatic Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct s,  Pancreatic Cancer - Pipeline Review, H1 2016 , provides an overview of the Pancreatic Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatic Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pancreatic Cancer and features dormant and discontinued projects. Global Markets Direct s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the global therapeutic landscape of Pancreatic Cancer - The report reviews pipeline therapeutics for Pancreatic Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Pancreatic Cancer therapeutics and enlists all their major and minor projects - The report assesses Pancreatic Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Pancreatic Cancer Reasons to buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Pancreatic Cancer - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Pancreatic Cancer pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

    • Release Date: June 28, 2016
    • Price: USD 2500
    • Format: pdf


Create Account



Log In Your Account